5-hidroxitriptophan — Competitive Intelligence Brief

5-hidroxitriptophan (5-hidroxitriptophan) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Serotonin precursor / amino acid supplement. Area: Psychiatry / Neurology / Pain Management.

phase 2 Serotonin precursor / amino acid supplement Aromatic amino acid decarboxylase (indirect); serotonergic system Psychiatry / Neurology / Pain Management Small molecule

Target snapshot

5-hidroxitriptophan (5-hidroxitriptophan) — Clinical Academic Center (2CA-Braga). 5-hydroxytryptophan (5-HTP) is a precursor to serotonin that increases central nervous system serotonin levels by crossing the blood-brain barrier and being converted to serotonin via aromatic amino acid decarboxylase.

Comparator set (1 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
5-hidroxitriptophan TARGET	5-hidroxitriptophan	Clinical Academic Center (2CA-Braga)	phase 2	Serotonin precursor / amino acid supplement	Aromatic amino acid decarboxylase (indirect); serotonergic system
5-Hydroxytryptophan	5-Hydroxytryptophan	Elizabeth Berry-Kravis	marketed	Serotonin precursor / amino acid supplement	Aromatic amino acid decarboxylase (enzyme substrate); indirect serotonin system modulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Serotonin precursor / amino acid supplement class)

1. Clinical Academic Center (2CA-Braga) · 1 drug in this class
2. Elizabeth Berry-Kravis · 1 drug in this class